News Article
Riber revenues shift from cells & sources to systems
The firm has reported yearly and quarterly results
Riber, a provider of MBE kits, recorded €16.7 million euros in revenues at the end of September 2012.
Revenues for the third quarter of 2012 came to €7.3 million, compared with €5.5 million for the third quarter of 2011.
Revenues came to €16.7 million at the end of September 2012, reflecting a change in the product mix in favour of the MBE system sales business.
As of September 30th, 2012, 10 MBE machines were billed, compared with 5 during the same period in 2011. This commercial success is paving the way for gains in Riber's market shares, particularly in the research sector.
Sales of services and accessories are stable in relation to the previous year, in an environment marked by the economic downturn.
.jpg)
Sales of evaporation sources and cells are significantly lower than the previous year, which had benefited from high levels of sales of equipment for OLED production in 2011.
On September 30th, 2012, the breakdown of Riber's revenues was as follows: Europe (43 percent), Asia (40 percent) and North America (17 percent).
Outlook
During the third quarter of 2012, Riber recorded two research system orders for laboratories in China and India, compared with three research systems during the third quarter of 2011. On September 30th, 2012, the order book represented €18.0 million (€19.3 million one year ago), comprising 14 MBE systems to be delivered between 2012 and 2013.
For cells and sources, the order book is down following the difficulties currently faced by the photovoltaic sector, as well as the ongoing development of new ranges of OLED cells in anticipation of the next waves of investments.
The order book for services and accessories should be stable over the year.
Riber is able to confirm its target for revenues between €26 and 28 million in 2012, with an operating margin ratio representing 7 to 9 percent of revenues.
2012 full-year revenues will be released on January 23rd, 2013 (after close of trading).
Revenues for the third quarter of 2012 came to €7.3 million, compared with €5.5 million for the third quarter of 2011.
Revenues came to €16.7 million at the end of September 2012, reflecting a change in the product mix in favour of the MBE system sales business.
As of September 30th, 2012, 10 MBE machines were billed, compared with 5 during the same period in 2011. This commercial success is paving the way for gains in Riber's market shares, particularly in the research sector.
Sales of services and accessories are stable in relation to the previous year, in an environment marked by the economic downturn.
Sales of evaporation sources and cells are significantly lower than the previous year, which had benefited from high levels of sales of equipment for OLED production in 2011.
On September 30th, 2012, the breakdown of Riber's revenues was as follows: Europe (43 percent), Asia (40 percent) and North America (17 percent).
Outlook
During the third quarter of 2012, Riber recorded two research system orders for laboratories in China and India, compared with three research systems during the third quarter of 2011. On September 30th, 2012, the order book represented €18.0 million (€19.3 million one year ago), comprising 14 MBE systems to be delivered between 2012 and 2013.
For cells and sources, the order book is down following the difficulties currently faced by the photovoltaic sector, as well as the ongoing development of new ranges of OLED cells in anticipation of the next waves of investments.
The order book for services and accessories should be stable over the year.
Riber is able to confirm its target for revenues between €26 and 28 million in 2012, with an operating margin ratio representing 7 to 9 percent of revenues.
2012 full-year revenues will be released on January 23rd, 2013 (after close of trading).
